Cutler Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-28,500
Closed -$10K 3982
2023
Q2
$10K Buy
+28,500
New +$35.5K ﹤0.01% 2248
2022
Q4
Sell
-2,200
Closed -$6K 4687
2022
Q3
$6K Sell
2,200
-1,700
-44% -$21.1K ﹤0.01% 3493
2022
Q2
$1K Buy
+3,900
New +$30.2K ﹤0.01% 4581
2020
Q1
Sell
-2,500
Closed -$1K 4246
2019
Q4
$1K Buy
+2,500
New +$50.4K ﹤0.01% 3667

Other funds holding GOSS

Cutler Group's GOSS Position: Q3 2023 in Review

Cutler Group sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 1,400 shares — an estimated $1K sold.

Cutler Group first reported a position in GOSS in Q4 2019 and held it in 9 quarters. The position peaked at $31K in Q3 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Cutler Group reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,400 Gossamer Bio shares in Q3 2023, an estimated $1K.
  • Cutler Group first reported a position in Gossamer Bio in Q4 2019 and held it in 9 quarters.
  • Cutler Group's Gossamer Bio position peaked at $31K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.